Free Trial
NASDAQ:ABP

Abpro (ABP) Stock Price, News & Analysis

Abpro logo
$0.21 -0.02 (-7.83%)
As of 05/23/2025 04:00 PM Eastern

About Abpro Stock (NASDAQ:ABP)

Key Stats

Today's Range
$0.20
$0.23
50-Day Range
$0.17
$0.48
52-Week Range
$0.15
$13.00
Volume
2.58 million shs
Average Volume
5.71 million shs
Market Capitalization
$11.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
Consensus Rating
Buy

Company Overview

Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

Receive ABP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abpro and its competitors with MarketBeat's FREE daily newsletter.

ABP Stock News Headlines

Abpro Holdings, Celltrion unveils preclinical data for ABP-102/CT-P72
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
Abpro Holdings announces departure of CEO Ian Chan
See More Headlines

ABP Stock Analysis - Frequently Asked Questions

Abpro's stock was trading at $1.79 at the beginning of 2025. Since then, ABP stock has decreased by 88.2% and is now trading at $0.2120.
View the best growth stocks for 2025 here
.

Abpro Co. (NASDAQ:ABP) announced its quarterly earnings data on Thursday, May, 15th. The company reported ($0.08) EPS for the quarter.

Abpro (ABP) raised $60 million in an initial public offering on Friday, May 11th 2018. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. UBS Investment Bank and Wells Fargo Securities served as the underwriters for the IPO and Nomura and Oppenheimer were co-managers.

Abpro's top institutional investors include Goldman Sachs Group Inc. (0.14%).
View institutional ownership trends
.

Shares of ABP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
5/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Holding & other investment offices
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ABP
Fax
N/A
Employees
15
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.00
High Stock Price Target
$4.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+1,786.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$183,000.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
4,565,000
Market Cap
$11.07 million
Optionable
N/A
Beta
-0.01
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:ABP) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners